News and Announcements

Read the latest news from Northwestern University Feinberg School of Medicine’s Parkinson's Disease and Movement Disorders Center. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards, and honors.

  • Funding Opportunity with Two Grant Initiatives
    06.20.2014

    Northwestern Memorial Foundation announces the availability of the 2015 Paul Ruby Foundation for Parkinson’s Research Grants Initiative and the 2015 Northwestern Parkinson’s Disease and Movement Disorders Advisory Council Grants Initiative.  At this time, proposals for both awards will be accepted for innovative contributions to the understanding, research and treatment of Parkinson’s Disease. Both initiatives are seeking proposals that impact patient care through translational clinical research studies.  Prospective proposals will be ones which provide support for all work associated with Parkinson’s Disease prevention, diagnosis, and treatment. The deadline to submit applications to trupti@northwestern.edu is Friday, September 5, 2014 by 5:00 p.m.

    Download an Application

    2015 Paul Ruby Foundation for Parkinson’s Research Grants Initiative

    2015 Northwestern Parkinson’s Disease and Movement Disorders Advisory Council Grants Initiative

    For questions, please feel free to email Trupti Patel or call 312-503-3320.

  • 2014 Cures Within Reach Research Patient Impact Award
    06.18.2014

    Drs. Tanya Simuni and Jim Surmeier were selected to receive the 2014 Cures Within Reach Research Patient Impact Award, which was presented, at the Bioscience Awards of the Midwest event on June 17, 2014.  Congratulations!

  • 05.03.2014
    Center study featured in the Chicago Sun Times for May 3, 2014.
  • 04.02.2014
    Tanya Simuni, MD, medical director of Northwestern University’s Parkinson’s Disease and Movement Disorders Center, was awarded a grant from the National Institutes of Health (NIH) to conduct a $16 million phase III study of the safety and efficacy of the drug isradipine as a potential neuroprotective agent in Parkinson’s disease.
  • Long-term Clinical Outcomes After Fetal Cell Transplantation in Parkinson Disease Implications for the Future of Cell Therapy
    02.12.2014
  • 01.31.2014

    Recognized for its approach to uncovering new therapeutic targets in the fight against Parkinson’s disease (PD), Northwestern University Feinberg School of Medicine will continue that pursuit as a National Institutes of Health Center of Excellence. The only medical school to receive new or renewed designation as a Morris K. Udall Center of Excellence for Parkinson’s Disease Research in 2013, Feinberg became the Midwest’s first site in 2003, and today is one of just 10 nationwide.